Skip to main content

Table 2 NPC incidence in China in 2013

From: Nasopharyngeal carcinoma incidence and mortality in China, 2013

Areas

Sex

CR (1/105)

Prop (%)

ASIRC (1/105)

ASIRW (1/105)

Cum rate (%)

TASR (1/105)

Rank

All

Both

3.09

1.14

2.31

2.17

0.24

4.88

19

Male

4.31

1.47

3.26

3.07

0.34

7.01

14

Female

1.81

0.74

1.35

1.25

0.13

2.68

19

Urban areas

Both

3.33

1.17

2.40

2.23

0.24

5.09

20

Male

4.73

1.58

3.43

3.21

0.35

7.37

14

Female

1.87

0.70

1.35

1.24

0.13

2.71

19

Rural areas

Both

2.82

1.11

2.19

2.07

0.23

4.59

19

Male

3.82

1.33

3.04

2.89

0.32

6.50

12

Female

1.75

0.79

1.34

1.26

0.14

2.65

20

Eastern area

Both

2.93

0.96

2.07

1.93

0.21

5.52

19

Male

4.14

1.23

2.94

2.76

0.31

8.17

14

Female

1.71

0.61

1.21

1.11

0.12

2.67

20

Middle area

Both

2.89

1.15

2.25

2.15

0.24

4.77

21

Male

3.98

1.42

3.16

3.02

0.34

6.47

15

Female

1.74

0.78

1.33

1.26

0.14

2.95

20

Western area

Both

4.57

1.86

3.58

3.37

0.37

6.58

18

Male

6.35

2.25

5.03

4.73

0.52

8.78

14

Female

2.72

1.32

2.12

1.99

0.21

4.31

19

  1. CR crude rate, Prop proportion, ASIRC age-standardized incidence rate by 2000 Chinese standard population, ASIRW age-standardized incidence rate by 1985 Segi’s world standard population, Cum rate cumulative rate for patients aged 0–74 years, TASR truncated age-standardized rate for patients aged 35–64 years, Rank rank of NPC incidence in all cancers’ incidences
Back to article page

Cancer Communications

ISSN: 2523-3548

Contact us